Option Care Health (NASDAQ:OPCH) Announces Quarterly Earnings Results

Key Points

• Option Care Health reported quarterly EPS of $0.49, matching consensus, while revenue of $1.49 billion topped estimates of $1.48 billion and rose 4.1% year over year.
• Analyst sentiment was mostly cautious: 14 analysts rated the stock Hold and two rated it Buy, with a consensus price target of $29.48.
• Two law firms announced investigations into the fairness of a merger involving OPCH; the reports provided no findings, leaving the potential shareholder impact unclear.

Option Care Health (NASDAQ:OPCH - Get Free Report) posted its earnings results on Wednesday. The company reported $0.49 earnings per share for the quarter, meeting the consensus estimate of $0.49, FiscalAI reports. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The business's revenue was up 4.1% compared to the same quarter last year. During the same period last year, the company earned $0.45 earnings per share.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH traded down $0.07 on Wednesday, hitting $31.70. 2,025,721 shares of the company were exchanged, compared to its average volume of 2,976,403. The company's 50 day moving average price is $26.83 and its two-hundred day moving average price is $26.44. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The firm has a market capitalization of $4.75 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.93 and a beta of 0.47.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on OPCH shares. William Blair downgraded Option Care Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, October 6th. Weiss Ratings upgraded shares of Option Care Health from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, October 20th. Citizens Jmp downgraded shares of Option Care Health from a "market outperform" rating to a "hold" rating in a report on Wednesday, October 7th. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and boosted their target price for the stock from $28.00 to $32.05 in a research report on Tuesday, October 6th. Finally, Morgan Stanley set a $32.05 price target on shares of Option Care Health in a report on Monday, October 12th. Two equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $29.48.

Option Care Health News Summary

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Q3 revenue rose 4.1% year over year to $1.49 billion, topping estimates of about $1.48 billion. Adjusted earnings were $0.49 per share, matching the $0.49 consensus cited by several reports and beating Zacks’ $0.48 estimate; EPS was up from $0.45 a year earlier. Option Care Health Q3 results Zacks Q3 earnings report
• Neutral Sentiment: Two law firms announced investigations related to the fairness of a merger involving OPCH. The notices provide no specific findings or details in the supplied reports, so the implications for shareholders—and any potential effect on the stock—are unclear. Merger investigation notice

About Option Care Health

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients' homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.